Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 2
2011 1
2013 1
2014 1
2017 2
2018 3
2019 7
2020 3
2021 5
2022 6
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study.
Gerbitz A, Gary R, Aigner M, Moosmann A, Kremer A, Schmid C, Hirschbuehl K, Wagner E, Hauptrock B, Teschner D, Roesler W, Spriewald B, Tischer J, Moi S, Balzer H, Schaffer S, Bausenwein J, Wagner A, Schmidt F, Brestrich J, Ullrich B, Maas S, Herold S, Strobel J, Zimmermann R, Weisbach V, Hansmann L, Lammoglia-Cobo F, Remberger M, Stelljes M, Ayuk F, Zeiser R, Mackensen A. Gerbitz A, et al. Among authors: teschner d. Front Immunol. 2023 Oct 30;14:1251593. doi: 10.3389/fimmu.2023.1251593. eCollection 2023. Front Immunol. 2023. PMID: 37965339 Free PMC article. Clinical Trial.
Chlorhexidine gluconate-coated gel pad dressings for prevention of central venous catheter-related bloodstream infections in patients with hematologic diseases or autologous stem cell transplantation: A registry-based matched-pair analysis.
Teschner D, Berisha M, Panse J, Schmitt T, Fiegle E, Naendrup JH, Neitz J, Schmidt-Hieber M, Hentrich M, Böll B, Schalk E. Teschner D, et al. Eur J Haematol. 2023 Dec;111(6):914-921. doi: 10.1111/ejh.14098. Epub 2023 Sep 13. Eur J Haematol. 2023. PMID: 37705250
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
Stemler J, Mellinghoff SC, Khodamoradi Y, Sprute R, Classen AY, Zapke SE, Hoenigl M, Krause R, Schmidt-Hieber M, Heinz WJ, Klein M, Koehler P, Liss B, Koldehoff M, Buhl C, Penack O, Maschmeyer G, Schalk E, Lass-Flörl C, Karthaus M, Ruhnke M, Cornely OA, Teschner D. Stemler J, et al. Among authors: teschner d. J Antimicrob Chemother. 2023 Aug 2;78(8):1813-1826. doi: 10.1093/jac/dkad143. J Antimicrob Chemother. 2023. PMID: 37311136 Free PMC article. Review.
Impact of the insertion site of central venous catheters on central venous catheter-related bloodstream infections in patients with cancer: results from a large prospective registry.
Hentrich M, Böll B, Teschner D, Panse J, Schmitt T, Naendrup JH, Schmidt-Hieber M, Neitz J, Fiegle E, Schalk E. Hentrich M, et al. Among authors: teschner d. Infection. 2023 Aug;51(4):1153-1159. doi: 10.1007/s15010-023-02029-4. Epub 2023 Apr 4. Infection. 2023. PMID: 37016194
Performance of T-Track® TB, a Novel Dual Marker RT-qPCR-Based Whole-Blood Test for Improved Detection of Active Tuberculosis.
Meier JP, Möbus S, Heigl F, Asbach-Nitzsche A, Niller HH, Plentz A, Avsar K, Heiß-Neumann M, Schaaf B, Cassens U, Seese B, Teschner D, Handzhiev S, Graf U, Lübbert C, Steinmaurer M, Kontogianni K, Berg C, Maieron A, Blaas SH, Wagner R, Deml L, Barabas S. Meier JP, et al. Among authors: teschner d. Diagnostics (Basel). 2023 Feb 16;13(4):758. doi: 10.3390/diagnostics13040758. Diagnostics (Basel). 2023. PMID: 36832246 Free PMC article.
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial.
Thompson GR 3rd, Soriano A, Cornely OA, Kullberg BJ, Kollef M, Vazquez J, Honore PM, Bassetti M, Pullman J, Chayakulkeeree M, Poromanski I, Dignani C, Das AF, Sandison T, Pappas PG; ReSTORE trial investigators. Thompson GR 3rd, et al. Lancet. 2023 Jan 7;401(10370):49-59. doi: 10.1016/S0140-6736(22)02324-8. Epub 2022 Nov 25. Lancet. 2023. PMID: 36442484 Clinical Trial.
Scheduled removal of central venous catheters (CVC) to prevent CVC-related bloodstream infections in patients with hematological disease or autologous stem cell transplantation: a registry-based randomized simulation-study.
Panse J, Tölle D, Fiegle E, Naendrup JH, Schmidt-Hieber M, Böll B, Hentrich M, Teschner D, Schalk E. Panse J, et al. Among authors: teschner d. Ann Hematol. 2022 Oct;101(10):2317-2324. doi: 10.1007/s00277-022-04958-w. Epub 2022 Aug 17. Ann Hematol. 2022. PMID: 35978182 Free PMC article.
Parainfluenza virus infections in patients with hematological malignancies or stem cell transplantation: Analysis of clinical characteristics, nosocomial transmission and viral shedding.
Tabatabai J, Schnitzler P, Prifert C, Schiller M, Weissbrich B, von Lilienfeld-Toal M, Teschner D, Jordan K, Müller-Tidow C, Egerer G, Giesen N. Tabatabai J, et al. Among authors: teschner d. PLoS One. 2022 Jul 29;17(7):e0271756. doi: 10.1371/journal.pone.0271756. eCollection 2022. PLoS One. 2022. PMID: 35905071 Free PMC article.
35 results